GSK’s Head Of Artificial Intelligence Unveils R&D Goals

GSK’s John Baldoni talks to Scrip in an exclusive interview about taking over the big pharma’s artificial intelligence R&D strategy and the company’s early-stage progress using machine-driven discovery and development methods.